M. Gill Hartley

1.0k total citations
20 papers, 714 citations indexed

About

M. Gill Hartley is a scholar working on Molecular Biology, Infectious Diseases and Genetics. According to data from OpenAlex, M. Gill Hartley has authored 20 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Infectious Diseases and 6 papers in Genetics. Recurrent topics in M. Gill Hartley's work include Bacillus and Francisella bacterial research (8 papers), Vector-borne infectious diseases (6 papers) and Mosquito-borne diseases and control (5 papers). M. Gill Hartley is often cited by papers focused on Bacillus and Francisella bacterial research (8 papers), Vector-borne infectious diseases (6 papers) and Mosquito-borne diseases and control (5 papers). M. Gill Hartley collaborates with scholars based in United Kingdom, United States and France. M. Gill Hartley's co-authors include Petra C. F. Oyston, Roman A. Lukaszewski, Rosa R. Taylor, Dermot Kenny, Timothy P. Atkins, Sally Roberts, Kate F. Griffin, Jim Eyles, Richard W. Titball and Berkay Unal and has published in prestigious journals such as Bioinformatics, Journal of Virology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

M. Gill Hartley

20 papers receiving 699 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Gill Hartley United Kingdom 13 363 240 188 137 112 20 714
Nicola J. Walker United Kingdom 13 286 0.8× 161 0.7× 92 0.5× 121 0.9× 33 0.3× 19 495
Deborah M. B. Post United States 16 344 0.9× 143 0.6× 152 0.8× 70 0.5× 31 0.3× 22 776
Iain G. Old France 15 255 0.7× 111 0.5× 72 0.4× 165 1.2× 183 1.6× 22 632
Patrick Sanz United States 13 438 1.2× 222 0.9× 93 0.5× 131 1.0× 26 0.2× 19 627
Cyril Badaut France 13 269 0.7× 232 1.0× 79 0.4× 99 0.7× 38 0.3× 29 709
Wilson J. Ribot United States 16 627 1.7× 382 1.6× 365 1.9× 169 1.2× 48 0.4× 27 1.2k
Kerstin Paprotka Germany 13 375 1.0× 83 0.3× 104 0.6× 291 2.1× 77 0.7× 20 672
Hua Niu China 18 287 0.8× 101 0.4× 188 1.0× 214 1.6× 338 3.0× 38 994
Daniel Bruno United States 14 183 0.5× 145 0.6× 243 1.3× 176 1.3× 84 0.8× 28 724
Berkay Unal United States 9 414 1.1× 57 0.2× 162 0.9× 128 0.9× 132 1.2× 9 739

Countries citing papers authored by M. Gill Hartley

Since Specialization
Citations

This map shows the geographic impact of M. Gill Hartley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Gill Hartley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Gill Hartley more than expected).

Fields of papers citing papers by M. Gill Hartley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Gill Hartley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Gill Hartley. The network helps show where M. Gill Hartley may publish in the future.

Co-authorship network of co-authors of M. Gill Hartley

This figure shows the co-authorship network connecting the top 25 collaborators of M. Gill Hartley. A scholar is included among the top collaborators of M. Gill Hartley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Gill Hartley. M. Gill Hartley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hartley, M. Gill, Isobel H. Norville, Kevin R. Bewley, et al.. (2021). Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever. Frontiers in Microbiology. 12. 760698–760698. 5 indexed citations
2.
Hartley, M. Gill, Stuart J. Armstrong, Kevin R. Bewley, et al.. (2021). Evaluation of the Efficacy of Doxycycline, Ciprofloxacin, Levofloxacin, and Co-trimoxazole Using In Vitro and In Vivo Models of Q Fever. Antimicrobial Agents and Chemotherapy. 65(11). e0067321–e0067321. 5 indexed citations
3.
Hartley, M. Gill, et al.. (2019). Comparison of PCR and Viable Count as a Method for Enumeration of Bacteria in an A/J Mouse Aerosol Model of Q Fever. Frontiers in Microbiology. 10. 1552–1552. 8 indexed citations
4.
Bryant, Jennifer, Nikolaos Batis, M. Gill Hartley, et al.. (2019). Repurposed quinacrine synergizes with cisplatin, reducing the effective dose required for treatment of head and neck squamous cell carcinoma. Oncotarget. 10(50). 5229–5244. 12 indexed citations
5.
Hartley, M. Gill, et al.. (2017). Use of axenic media to determine antibiotic efficacy against coxiella burnetii. International Journal of Antimicrobial Agents. 51(5). 806–808. 7 indexed citations
6.
Wasson, Christopher W., Ethan L. Morgan, Marietta Müller, et al.. (2017). Human papillomavirus type 18 E5 oncogene supports cell cycle progression and impairs epithelial differentiation by modulating growth factor receptor signalling during the virus life cycle. Oncotarget. 8(61). 103581–103600. 56 indexed citations
7.
Norville, Isobel H., M. Gill Hartley, Eric Martínez, et al.. (2014). Galleria mellonella as an alternative model of Coxiella burnetii infection. Microbiology. 160(6). 1175–1181. 35 indexed citations
8.
9.
10.
Rowland, Caroline A., M. Gill Hartley, Helen C. Flick-Smith, et al.. (2012). Peripheral human γδ T cells control growth of both avirulent and highly virulent strains of Francisella tularensis in vitro. Microbes and Infection. 14(7-8). 584–589. 6 indexed citations
11.
Weller, Simon A., Victoria Cox, Angela Essex-Lopresti, et al.. (2012). Evaluation of two multiplex real-time PCR screening capabilities for the detection of Bacillus anthracis, Francisella tularensis and Yersinia pestis in blood samples generated from murine infection models. Journal of Medical Microbiology. 61(11). 1546–1555. 31 indexed citations
12.
Michell, Stephen, Rachel E. Dean, Jim Eyles, et al.. (2010). Deletion of the Bacillus anthracis capB homologue in Francisella tularensis subspecies tularensis generates an attenuated strain that protects mice against virulent tularaemia. Journal of Medical Microbiology. 59(11). 1275–1284. 17 indexed citations
13.
Eyles, Jim, M. Gill Hartley, Thomas R. Laws, et al.. (2007). Protection afforded against aerosol challenge by systemic immunisation with inactivated Francisella tularensis live vaccine strain (LVS). Microbial Pathogenesis. 44(2). 164–168. 31 indexed citations
14.
Eyles, Jim, Berkay Unal, M. Gill Hartley, et al.. (2007). Immunodominant Francisella tularensis antigens identified using proteome microarray. ©Crown Copyright 2007 Dstl. PROTEOMICS. 7(13). 2172–2183. 93 indexed citations
15.
Sundaresh, Suman, Arlo Randall, Berkay Unal, et al.. (2007). From protein microarrays to diagnostic antigen discovery: a study of the pathogen Francisella tularensis. Bioinformatics. 23(13). i508–i518. 68 indexed citations
16.
Lukaszewski, Roman A., et al.. (2005). Pathogenesis of Yersinia pestis Infection in BALB/c Mice: Effects on Host Macrophages and Neutrophils. Infection and Immunity. 73(11). 7142–7150. 124 indexed citations
17.
Garmory, Helen S., Kate F. Griffin, Stephen J. Elvin, et al.. (2005). Antibiotic-Free Plasmid Stabilization by Operator-Repressor Titration for Vaccine Delivery by Using Live Salmonella enterica Serovar Typhimurium. Infection and Immunity. 73(4). 2005–2011. 40 indexed citations
18.
Essex-Lopresti, Angela, Justin A. Boddey, Richard J. Thomas, et al.. (2005). A Type IV Pilin, PilA, Contributes to Adherence ofBurkholderia pseudomalleiand Virulence In Vivo. Infection and Immunity. 73(2). 1260–1264. 82 indexed citations
19.
Perkins, Stuart D., M. Gill Hartley, Roman A. Lukaszewski, et al.. (2004). VP22 enhances antibody responses from DNA vaccines but not by intercellular spread. Vaccine. 23(16). 1931–1940. 23 indexed citations
20.
Hartley, M. Gill, et al.. (2004). Protection Afforded by Heat Shock Protein 60 fromFrancisella tularensisIs Due to Copurified Lipopolysaccharide. Infection and Immunity. 72(7). 4109–4113. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicola J. Walker Breakdown of academic impact, for papers by Deborah M. B. Post Breakdown of academic impact, for papers by Iain G. Old Breakdown of academic impact, for papers by Patrick Sanz Breakdown of academic impact, for papers by Cyril Badaut Breakdown of academic impact, for papers by Wilson J. Ribot Breakdown of academic impact, for papers by Kerstin Paprotka Breakdown of academic impact, for papers by Hua Niu Breakdown of academic impact, for papers by Daniel Bruno Breakdown of academic impact, for papers by Berkay Unal
Rankless by CCL
2026